Profilaxi Pre-exposició en adults per la Prevenció d'infecció per VIH. (Catalan Wikipedia)

Analysis of information sources in references of the Wikipedia article "Profilaxi Pre-exposició en adults per la Prevenció d'infecció per VIH." in Catalan language version.

refsWebsite

Global rank Catalan rank

30nih.gov

4^th place

7^th place

4croiconference.org

low place

3nejm.org

2,374^th place

2,440^th place

1gesida-seimc.org

low place

1plos.org

2,112^th place

1,030^th place

1jamanetwork.com

2,650^th place

3,376^th place

1retroconference.org

low place

1i-base.info

low place

1web.archive.org

1^st place

1cdc.gov

218^th place

281^st place

cdc.gov

npin.cdc.gov

Gibson, S. «Launches PrEP Health Program in Community-Based Sexual Health Center. 2015 National HIV Prevention Conference. 6-9 december. Atlanta, Ga. Abstract ID 1834.». Launches PrEP Health Program in Community-Based Sexual Health Center. 2015 National HIV Prevention Conference. 6-9 december. Atlanta, Ga. Abstract ID 1834., December 6-9, 2015. Arxivat de l'original el 2019-06-01 [Consulta: 1r juny 2019].

croiconference.org

Gulick, R. «HPTN 069/ACTG5305: Phase II Study of Maraviroc-Based Regiments for HIV PrEP in MSM. Conference on Retrovirus and Opportunistic Infections (CROI), February 22-25, 2016. Boston. Abstract 103.». HPTN 069/ACTG5305: Phase II Study of Maraviroc-Based Regiments for HIV PrEP in MSM. Conference on Retrovirus and Opportunistic Infections (CROI), February 22-25, 2016. Boston. Abstract 103., 2 febrer 2–25, 2016.
Rees, H. «FACTS 001 phase IIItrial of pericoital tenofovir 1% gel for HIV prevention in women. Conference on Retroviruses and Opportunistic Infections; February 23-26, 2015; Seattle, Washington.». FACTS 001 phase IIItrial of pericoital tenofovir 1% gel for HIV prevention in women. Conference on Retroviruses and Opportunistic Infections; February 23-26, 2015; Seattle, Washington., March 4–7, 2019.
Glidden, DV. «PrEP Engagement for HIV Prevention: Results from the iPrEx Open Label Extension. Conference on Retroviruses and Opportunistic Infections; February 23-26, 2015; Seattle, Washington. Abstract 970.». PrEP Engagement for HIV Prevention: Results from the iPrEx Open Label Extension. Conference on Retroviruses and Opportunistic Infections; February 23-26, 2015; Seattle, Washington. Abstract 970., febrer 23-26, 2015.
Baeten, J. «Near elimination of HIV transmission in a demonstration project of PrEP and ART. Conference on Retroviruses and Opportunistic infections; February 23-26, 2015; Seattle, Washington.». Near elimination of HIV transmission in a demonstration project of PrEP and ART. Conference on Retroviruses and Opportunistic infections; February 23-26, 2015; Seattle, Washington., febrer 23-26, 2015.

gesida-seimc.org

«Grupo de Estudio de Sida de la SEIMC (GeSIDA)».- <ref>García-Lerma, Gerardo «Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with Emtricitabine and Tenofovir.». Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with Emtricitabine and Tenofovir. PLoS medicine 2008;5:e28., 05-02-2008.

i-base.info

Wallace, M. «HPTN 067 ADAPT: "PrEP Ubuntu" and experiences with open-label PrEP among South African women. Program and abstracts of the 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention; July 19-22, 2015, Vancouver, Canada. Abstract TUPEC515.». HPTN 067 ADAPT: "PrEP Ubuntu" and experiences with open-label PrEP among South African women. Program and abstracts of the 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention; July 19-22, 2015, Vancouver, Canada. Abstract TUPEC515., July 19-22, 2015.

jamanetwork.com

Stephenson, J. «Study halted: no benefit seen from antiretroviral pill in preventing HIV in women. JAMA 2011;305:1952.». Study halted: no benefit seen from antiretroviral pill in preventing HIV in women. JAMA 2011;305:1952., 18-05-2011.

nejm.org

Molina, JM. «On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. N Engl J Med 2015;373:2237-46.». On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. N Engl J Med 2015;373:2237-46., 03-12-2015.
Baeten, JM. «Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N EngI J Med 2012;367-410.». Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N EngI J Med 2012;367-410., 02-08-2012.
Van Damme, L. «Preexposure prophylaxis for HIV infection among African women. N EngI J Med 2012;367:411-22.». Preexposure prophylaxis for HIV infection among African women. N EngI J Med 2012;367:411-22., 02-08-2012.

nih.gov

ncbi.nlm.nih.gov

García-Lerma, Gerardo «Intermittent prophylaxis with oral truvada protects macaques from rectal SHIV infection.». Intermittent prophylaxis with oral truvada protects macaques from rectal SHIV infection., 13-01-2010.
Kelesidis, Theodoros «Current HIV/AIDS reports 2011». Preexposure prophylaxis for HIV prevention, 08-06-2011.
Patterson, K.B. «Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission. Sci Transl Med 2011;3:112re4.». Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission. Sci Transl Med 2011;3:112re4., 07-12-2011.
Spinner, C.D. «HIV preexposure prophylaxis (PrEP): a review of current Knowledge of oral systemic HIV PrEP in humans. Infection 2016;44:151-8.». HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans, 2016 Apr.
Grant, Robert M. «Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. NEngl J Med 2010;363:2587-99.». Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men, 23-11-2010.
Buchbinder, S:P. «HIV preexposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial. Lancet Infect Dis 2014;14:468-75.». HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial., 2014 Jun.
Liu, A. «Patterns and correlates of PrEP drug detection among MSM and transgenser women in the Global iPrEx Study.». Liu A, Glidden DV, Anderson PL, Amico KR, MvMahan V, Mehotra M, et al. Patterns and correlates of PrEP drug detection among MSM and transgenser women in the Global iPrEx Study. J Acquir Immune Defic Syndr 2014;67:528-37., 15-12-2014.
Deutsch, Madeline B. «HIV preexposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial. The lancet HIV 2015;2:e512-9.». HIV pre-exposure prophylaxis in transgender women: A subgroup analysis of the iPrEx trial, 06-11-2015.
Solomon, MM «Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis.». Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis. AIDS 2014;28:851-9., 27-03-2014.
Mulligan, K. «Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial.». Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial. Clin Infect Dis 2015;61:572-80., 15-08-2015.
Lieger, T. «HIV-1 drug resistance in the iPrEx preexposure prophylaxis trial». HIV-1 drug resistance in the iPrEx preexposure prophylaxis trial. J Infect Dis 2014;210:1217-27., 15-10-2014.
Marcus, JL «No evidebce of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis. PLoS One 2013;8:e81997.». Marcus JL, Glidden DV, Mayer KH, Liu AY Buchbinder SP, Amico KR, et al., 18-12-2013.
Solomon, MM «Syphilis predicts HIV incidence among men and transgender women who have sex with men in a preexposure prophylaxis trial. Clin infect Dis 2014;59:1020-6.». Syphilis predicts HIV incidence among men and transgender women who have sex with men in a preexposure prophylaxis trial. Clin infect Dis 2014;59:1020-6., 2014 Oct.
McCormack, S. «Pre-exposure prophylaxis to prevent the axquisition oh HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet 2015.». Pre-exposure prophylaxis to prevent the axquisition oh HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet 2015., 02-01-2016.
«Feasibility of intermittent PrEP among US MSM: Data from the Harlem site. En IAS 2015, 19-22 July 2015; Vancouver, CA. Abstract: MOAC0305LB.». Feasibility of intermittent PrEP among US MSM: Data from the Harlem site. En IAS 2015, 19-22 July 2015; Vancouver, CA. Abstract: MOAC0305LB., 2015 Apr.
Holtz, TH. «A comparison of daily and nondaily pre-exposure prophylaxis dosing in Thai men who have sex with men, Bangkok. In IAS 2015, 19-22 July 2015; Vancouver, CA. Abstract: MOAC0306LB.». A comparison of daily and nondaily pre-exposure prophylaxis dosing in Thai men who have sex with men, Bangkok. In IAS 2015, 19-22 July 2015; Vancouver, CA. Abstract: MOAC0306LB., 2018 May.
Thigpen, MC. «Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N EngI J Med 2012;367:423-24.». Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N EngI J Med 2012;367:423-24., 02-08-2012.
Marrazzo, JM. «Tenofovir-based preexposure prophylaxis for HIV infection among African Women. N EngI J Med 2015;372:509-18.». Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, et al., 05-02-2015.
Murnane, PM. «Efficacy of preexposure prophylaxis for HIV-1 prevention among high-risk heterosexuals: subgroup analyses from a randomized trial. AIDS 2013;27:2155-60.». Efficacy of preexposure prophylaxis for HIV-1 prevention among high-risk heterosexuals: subgroup analyses from a randomized trial. AIDS 2013;27:2155-60., 24-08-2013.
Abdool Karim, Q. «Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010;329:1168-74.». Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010;329:1168-74., 03-09-2010.
Pantaleo, G. «New concepts in the immunopathogenesis of human immunodeficiency virus infection. N EngI J Med 1993;328:327-35.». New concepts in the immunopathogenesis of human immunodeficiency virus infection. N EngI J Med 1993;328:327-35., 04-02-1993.
Choopanya, K. «Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2013;381:2083-90.». Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2013;381:2083-90., 15-06-2013.
Karim, SS. «HIV pre-exposure prophylaxis in injecting drug users. Lancet 2013;381:2060-2.». HIV pre-exposure prophylaxis in injecting drug users. Lancet 2013;381:2060-2., 15-06-2013.
Grant, RM. «Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis 2014;14:820-9.». Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis 2014;14:820-9., 2014 Sep.
Liu, AY. «Preexposure Prophylaxis for HIV Infection Integrated With Municipal-and Community-Based Sexual Health Services. JAMA internal medicine 2016;176:75-84.». Preexposure Prophylaxis for HIV Infection Integrated With Municipal-and Community-Based Sexual Health Services. JAMA internal medicine 2016;176:75-84., 2016 Jan.
Liu, AY. «Preexposure Prophylaxis for HIV infection Integrated With Municipal-and Community-BasedSexual Health Services. JAMA internal medicine 2016; 176:75-84». Preexposure Prophylaxis for HIV infection Integrated With Municipal-and Community-BasedSexual Health Services. JAMA internal medicine 2016; 176:75-84, 2016 Jan.
Volk, JE. «No New HIV Infections With Increasing Use of HIV preexposure Prophylaxis in a Clinical Practice Setting. Clin Infect Dis 2015;61:1601-3.». No New HIV Infections With Increasing Use of HIV preexposure Prophylaxis in a Clinical Practice Setting. Clin Infect Dis 2015;61:1601-3., 15-11-2015.
Marrazzo, JM. «HIV Prevention in Clinical Care Settings: 2014 Recommendations of the International Antiviral Society- USA Panel. JAMA 2014;312-409.». HIV Prevention in Clinical Care Settings: 2014 Recommendations of the International Antiviral Society- USA Panel. JAMA 2014;312-409., 2014 Jul 23-30.
Geneva: World Health Organization «Guideline on When to Start AntiretroviralTherapy and on Pre-exposure Prophylaxis for HIV. Geneva: World Health Organization; 2015 Sep. Disponible en: http://www.ncbi.nlm.nih.gov/books/NBK327115/pdf/Bookshelf_NBK327115.pdf (consultada 01.06.2016).Preexposure Prophylaxis for HIV Prevention». Guideline on When to Start AntiretroviralTherapy and on Pre-exposure Prophylaxis for HIV. Geneva: World Health Organization; 2015 Sep. Disponible en: http://www.ncbi.nlm.nih.gov/books/NBK327115/pdf/Bookshelf_NBK327115.pdf (consultada 01.06.2016).Preexposure Prophylaxis for HIV Prevention, 2015 Sep..
«Guideline on When to Start AntiretroviralTherapy and on Pre-exposure Prophylaxis for HIV. Geneva: World Health Organization; 2015 Sep. Disponible en: http://www.ncbi.nlm.nih.gov/books/NBK327115/pdf/Bookshelf_NBK327115.pdf (consultada 01.06.2016).Preexposure Prophylaxis for HIV Prevention». Guideline on When to Start AntiretroviralTherapy and on Pre-exposure Prophylaxis for HIV. Geneva: World Health Organization; 2015 Sep. Disponible en: http://www.ncbi.nlm.nih.gov/books/NBK327115/pdf/Bookshelf_NBK327115.pdf (consultada 01.06.2016).Preexposure Prophylaxis for HIV Prevention, 2015 Sep..

plos.org

journals.plos.org

«Grupo de Estudio de Sida de la SEIMC (GeSIDA)».- <ref>García-Lerma, Gerardo «Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with Emtricitabine and Tenofovir.». Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with Emtricitabine and Tenofovir. PLoS medicine 2008;5:e28., 05-02-2008.

retroconference.org

Van Damme, L. «The FEM-PrEP Trial of Emtricitabine/Tenofovir DisoproxilFumarate (Truvada) among African Women. Presented at the 19th Conference on Retroviruses and Opportunistic Infections, Seattle, WA, March 5-8, 2012. Abstract 32LB.». The FEM-PrEP Trial of Emtricitabine/Tenofovir DisoproxilFumarate (Truvada) among African Women. Presented at the 19th Conference on Retroviruses and Opportunistic Infections, Seattle, WA, March 5-8, 2012. Abstract 32LB., 08-03-2012.^{[Enllaç no actiu]}

web.archive.org

Gibson, S. «Launches PrEP Health Program in Community-Based Sexual Health Center. 2015 National HIV Prevention Conference. 6-9 december. Atlanta, Ga. Abstract ID 1834.». Launches PrEP Health Program in Community-Based Sexual Health Center. 2015 National HIV Prevention Conference. 6-9 december. Atlanta, Ga. Abstract ID 1834., December 6-9, 2015. Arxivat de l'original el 2019-06-01 [Consulta: 1r juny 2019].